Jeffrey L. Purvin serves as Executive at RESPONSE BIOMEDICAL CORP, where they oversee executive responsibilities. Since joining the company, Jeffrey L. Purvin has executed 8 insider transactions totaling $45.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 4, 2013 involved purchasing 505 shares valued at $641.
Jeffrey L. Purvin currently holds 9,300 shares of RESPONSE BIOMEDICAL CORP (RBM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey L. Purvin has been a net buyer of RBM stock. They have purchased $45.0K and sold $0 worth of shares.
Jeffrey L. Purvin's most recent insider trade was on Dec 4, 2013, when they purchased 505 shares at $1.27 per share.
Get notified when new Form 4 filings are submitted
| $1.30 |
| Discretionary |
| Nov 29, 2013 | RBM | $1.0K | Purchase | 800 | $1.30 | Discretionary |
| Mar 19, 2013 | RBM | $15.4K | Purchase | 4,300 | $3.58 | Discretionary |
| Aug 17, 2012 | RBM | $3.1K | Purchase | 39,000 | $0.08 | Discretionary |
| Aug 17, 2012 | RBM | $3.1K | Purchase | 39,000 | $0.08 | Discretionary |
| Aug 16, 2012 | RBM | $12.9K | Purchase | 161,000 | $0.08 | Discretionary |
| Aug 15, 2012 | RBM | $4.0K | Purchase | 50,000 | $0.08 | Discretionary |